Feasibility study of a systematic approach for deprescribing of statins and proton pump inhibitors in nursing home residents

Feasibility study of a systematic approach for deprescribing of statins and proton pump inhibitors in nursing home residents - FeDeS+P

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON46524

Enrollment

125

Registered

2018-03-06

Start date

2018-04-02

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polyfarmacie polypharmacy the concurrent use of multiple medications by a patient

Interventions

For this study an implicit, evidence-supported and patient-centred algorithm has been developed. The outcome of the algorithm is an advice to the doctor to deprescribe or not deprescribe the statin

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participant uses a statin Or/and participant uses a proton pump inhibitor Participant signs informed consent

Exclusion criteria

Exclusion criteria: Participant is there for short term nursing home admission (

Design outcomes

Primary

Measure	Time frame
1. Decrease in PPI and statin use for the short and long term.	—

Secondary

Measure	Time frame
1. All possible negative effects of deprescribing 2. The feasibility and acceptance of this deprescribing proces for patients, family and doctors.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)